Laying the foundation for gene editing for inherited progressive deafness in adults

A study, published in the Journal of Clinical Investigation titled “Single Dose Genome Editing Therapy Rescues Auditory and Vestibular Functions in Adult Mice with DFNA41 Deafness,” provides an example of a successful use of gene-editing technology to treat a mouse model of human genetic hearing loss.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup